CAS 6556-11-2

Inositol nicotinate

Description:

Inositol nicotinate, with the CAS number 6556-11-2, is a chemical compound formed by the esterification of inositol and nicotinic acid (niacin). It is often used in dietary supplements and functional foods due to its potential health benefits, particularly in promoting cardiovascular health and improving circulation. The compound is characterized by its ability to release niacin in the body, which can help in the management of cholesterol levels and support overall metabolic functions. Inositol nicotinate is typically recognized for its vasodilatory properties, which may enhance blood flow and reduce the risk of vascular-related issues. Additionally, it is considered to have a lower flushing effect compared to standard niacin, making it more tolerable for some individuals. The compound is generally soluble in water and exhibits stability under normal storage conditions. As with any supplement, it is important to consult healthcare professionals before use, especially for individuals with underlying health conditions or those taking other medications.

Formula: C₄₂H₃₀N₆O₁₂

InChI: InChI=1/C42H30N6O12/c49-37(25-7-1-13-43-19-25)55-31-32(56-38(50)26-8-2-14-44-20-26)34(58-40(52)28-10-4-16-46-22-28)36(60-42(54)30-12-6-18-48-24-30)35(59-41(53)29-11-5-17-47-23-29)33(31)57-39(51)27-9-3-15-45-21-27/h1-24,31-36H/t31-,32-,33-,34+,35-,36-

InChI key: InChIKey=MFZCIDXOLLEMOO-GYSGTQPENA-N

SMILES: O(C(=O)C=1C=CC=NC1)[C@@H]2[C@@H](OC(=O)C=3C=CC=NC3)[C@@H](OC(=O)C=4C=CC=NC4)[C@@H](OC(=O)C=5C=CC=NC5)[C@H](OC(=O)C=6C=CC=NC6)[C@H]2OC(=O)C=7C=CC=NC7

Synonyms:

• 3-Pyridinecarboxylic acid, 1,2,3,4,5,6-cyclohexanehexayl ester
• Cyclohexane-1,2,3,4,5,6-Hexayl Hexapyridine-3-Carboxylate
• Dilcit
• Dilexpal
• Esantene
• Hamovannid
• Hexanicit
• Hexanicotinoyl inositol
• Hexanicotol
• Hexopal
• Inositol Hexanicotinate
• Inositol Nicotinate
• Inositol hexaniacinate
• Inositol, hexanicotinate, myo-
• Linodil
• Meso-inositol hexanicotinate
• Mesonex
• Mesotal
• Myo-Inositol Hexanicotinate
• Nicotinic acid, hexaester with myo-inositol
• Palohex

Inositol Niacinate

CAS: 6556-11-2

Compounds containing an unfused pyridine ring in the structure, nesoi

Formula: C₄₂H₃₀N₆O₁₂

Color and Shape: Off-White Powder

Molecular weight: 810.19217

Ref: 45-1340982

myo-Inositol, hexa-3-pyridinecarboxylate

CAS: 6556-11-2

Formula: C₄₂H₃₀N₆O₁₂

Purity: 97%

Color and Shape: Solid

Molecular weight: 810.7206

Ref: IN-DA01CBWK

Inositol nicotinate

CAS: 6556-11-2

Inositol nicotinate

Purity: ≥95%

Molecular weight: 810.72g/mol

Ref: 54-BUP17196

myo-Inositol hexanicotinate

CAS: 6556-11-2

Formula: C₄₂H₃₀N₆O₁₂

Purity: ≥ 98.0%

Color and Shape: White to off-white powder

Molecular weight: 810.72

Ref: 7W-GC2821

Rel-(1R,2R,3S,4R,5S,6S)-Cyclohexane-1,2,3,4,5,6-Hexayl Hexanicotinate

CAS: 6556-11-2

Rel-(1R,2R,3S,4R,5S,6S)-Cyclohexane-1,2,3,4,5,6-Hexayl Hexanicotinate

Purity: 97%

Molecular weight: 810.72g/mol

Ref: 54-OR1028432

Inositol hexanicotinate

CAS: 6556-11-2

Formula: C₄₂H₃₀N₆O₁₂

Color and Shape: Off-White

Molecular weight: 810.72

Ref: 04-C14328220

Inositol nicotinate

CAS: 6556-11-2

Inositol nicotinate (Mesotal) has the effect of lowering cholesterol and expanding peripheral blood vessels for hypercholesterolemia and atherosclerosis.

Formula: C₄₂H₃₀N₆O₁₂

Purity: 97.33%

Color and Shape: White Powder

Molecular weight: 810.72

Ref: TM-T4509

INOSITOL NICOTINATE

CAS: 6556-11-2

Purity: 95%

Molecular weight: 810.7319946289062

Ref: 10-F807024

myo-Inositol Hexanicotinate

Controlled Product

CAS: 6556-11-2

Applications myo-Inositol Hexanicotinate is an nicotinate conjugate of myo-inositol, an structural basis for a number of secondary messengers.
References Harsha, K.P., et al.: J. Pharma. Res., 4, 217 (2011); Vilar, S., et al.: J. Med. Chem., 49, 1118 (2006);

Formula: C₄₂H₃₀N₆O₁₂

Color and Shape: Off-White

Molecular weight: 810.72

Ref: TR-I666070

Inositol nicotinate

CAS: 6556-11-2

Inositol nicotinate is a combination of two substances, inositol and nicotinate. It is used to reduce the risk of heart disease by lowering low-density lipoprotein-cholesterol (LDL) levels. Inositol nicotinate has been shown to increase the surface area of mitochondria, which may be due to its ability to inhibit the release of fatty acids from fat cells. Inositol nicotinate also increases magnesium levels in cells and induces mitochondrial functions. This drug has been tested in cell culture for its effects on skin cells and found that it can reduce the amount of x-linked adrenoleukodystrophy protein (XALD), a substance that accumulates in patients with X-linked adrenoleukodystrophy, an inherited disorder that causes progressive damage to the nervous system. The drugs also have been shown to have beneficial effects on cholesterol metabolism, reducing LDL cholesterol levels, as well as inhibiting platelet aggregation.

Formula: C₄₂H₃₀N₆O₁₂

Purity: Min. 95%

Color and Shape: White Powder

Molecular weight: 810.72 g/mol

Ref: 3D-MI33322

Inositol Nicotinate

CAS: 6556-11-2

Color and Shape: Neat

Ref: 61-FOR1758.00